Neurocrine Biosciences, Inc. (NBIX)
128.63
-1.47
(-1.13%)
USD |
NASDAQ |
Feb 20, 16:00
128.61
-0.02
(-0.02%)
After-Hours: 20:00
Neurocrine Biosciences Price : 128.63 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Glaukos Corp. | 120.27 |
| Edgewise Therapeutics, Inc. | 29.31 |
| Nuvalent, Inc. | 100.50 |
| Marker Therapeutics, Inc. | 1.45 |
| CapsoVision, Inc. | 4.68 |
Price Related Metrics
| PE Ratio | 27.56 |
| PS Ratio | 4.606 |
| PEG Ratio | 0.6588 |
| Price to Book Value | 3.968 |
| Price to Free Cash Flow | 17.60 |
| Earnings Yield | 3.63% |
| Market Cap | 12.91B |
| PEGY Ratio | 0.6588 |
| Operating PE Ratio | 20.70 |
| Normalized PE Ratio | 26.72 |